The Donald Trump administration is considering speeding up the availability of the experimental Convid-19 vaccine from the UK ahead of the presidential polls in November, the Financial Times reported. The vaccine candidate the Trump administration is targeting for fast tracking is being developed by Oxford university in partnership with AstraZeneca.

The #DonaldTrump (@realDonaldTrump) administration is considering speeding up the availability of the experimental #Covid19vaccine from the UK ahead of the presidential polls in November, the Financial Times reported.#coronavirus pic.twitter.com/Dm9yVXuC2p

— IANS Tweets (@ians_india) August 24, 2020

One route that is being explored is the possibility of an "emergency use authorisation" of the vaccine by the US Food and Drug Administration (FDA) based on positive results from a relatively small UK study, said the report on Sunday which cited people familiar with the plan.